Pricing Log in Create free account

Evotec AG (EVO) vs Alpha Teknova, Inc. (TKNO)

Evotec AG and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $630.4M against $486.2M — 1.3× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 15.5% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −34.8%) and the higher return on invested capital (0.00% vs −16.6%). Across the 18 metrics below, Evotec AG leads on 12 and Alpha Teknova, Inc. on 6.

Valuation

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.72 9.15 2.08
P/B 0.81 7.03 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.74 9.17 2.87
Earnings yield (36.25%) (3.70%) (15.94%)
Free cash flow yield (32.04%) (1.52%) 0.00%

Profitability

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Gross margin 11.42% 36.43% 53.51%
Operating margin (21.35%) (32.65%) 0.00%
Net margin (26.20%) (34.76%) (2.45%)
Free cash flow margin 0.00% (13.89%) 0.00%
Return on equity 0.00% (24.12%) (0.80%)
Return on assets 0.00% (15.79%) (1.67%)
Return on invested capital 0.00% (16.60%) 0.00%

Growth

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.15% 15.45% 5.22%
EPS growth (last fiscal year) 44.89% 43.86% 42.91%
Revenue growth, 5-year CAGR 9.28% 5.30% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 0.72 0.22 0.04
Current ratio 2.33 3.56 2.41
Net debt to EBITDA (0.64) 0.75 1.01

Dividend

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric EVO TKNO Drug Manufacturers Specialty & Generic median
Market cap 630.44m 486.22m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack